{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:32:17Z","timestamp":1775554337762,"version":"3.50.1"},"reference-count":146,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cystic fibrosis (CF), the most common genetically inherited disease in Caucasian populations, is a multi-systemic life-threatening autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. In 2012, the arrival of CFTR modulators (potentiators, correctors, amplifiers, stabilizers, and read-through agents) revolutionized the therapeutic approach to CF. In this review, we examined the physiopathological mechanism of chronic dysregulated innate immune response in the lungs of CF patients with pulmonary involvement with particular reference to phagocytes, critically analyzing the role of CFTR modulators in influencing and eventually restoring their function. Our literature review highlighted that the role of CFTR in the lungs is crucial not only for the epithelial function but also for host defense, with particular reference to phagocytes. In macrophages and neutrophils, the CFTR dysfunction compromises both the intricate process of phagocytosis and the mechanisms of initiation and control of inflammation which then reverberates on the epithelial environment already burdened by the chronic colonization of pathogens leading to irreversible tissue damage. In this context, investigating the impact of CFTR modulators on phagocytic functions is therefore crucial not only for explaining the underlying mechanisms of pleiotropic effects of these molecules but also to better understand the physiopathological basis of this disease, still partly unexplored, and to develop new complementary or alternative therapeutic approaches.<\/jats:p>","DOI":"10.3390\/ijms232012421","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T21:11:51Z","timestamp":1666041111000},"page":"12421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3343-4051","authenticated-orcid":false,"given":"Aniello","family":"Meoli","sequence":"first","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"},{"name":"Division of Allergy, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, University Hospital, 60431 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Eickmeier","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, University Hospital, 60431 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Pisi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Fainardi","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zielen","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, University Hospital, 60431 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Gray","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"ref_2","first-page":"82","article-title":"Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles","volume":"5","author":"Mall","year":"2019","journal-title":"ERJ Open Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ghigo, A., Prono, G., Riccardi, E., and De Rose, V. (2021). Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041952"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ppul.24246","article-title":"Airway microenvironment alterations and pathogen growth in cystic fibrosis","volume":"54","author":"Rossi","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Laucirica, D.R., Garratt, L.W., and Kicic, A. (2020). Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00595"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-011-0185-9","article-title":"Intestinal Obstruction Syndromes in Cystic Fibrosis: Meconium Ileus, Distal Intestinal Obstruction Syndrome, and Constipation","volume":"13","author":"Kokke","year":"2011","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Meoli, A., Fainardi, V., Deolmi, M., Chiopris, G., Marinelli, F., Caminiti, C., Esposito, S., and Pisi, G. (2021). State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators and Triple-Combination Therapy. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090928"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Fran\u00e7oise, A., and H\u00e9ry-Arnaud, G. (2020). The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes, 11.","DOI":"10.3390\/genes11050536"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(16)30081-9","article-title":"The nasal microbiota in infants with cystic fibrosis in the first year of life: A prospective cohort study","volume":"4","author":"Mika","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_10","first-page":"96","article-title":"The cystic fibrosis lower airways microbial metagenome","volume":"2","author":"Losada","year":"2016","journal-title":"ERJ Open Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Keown, K., Brown, R., Doherty, D.F., Houston, C., McKelvey, M.C., Creane, S., Linden, D., McAuley, D.F., Kidney, J.C., and Weldon, S. (2020). Airway Inflammation and Host Responses in the Era of CFTR Modulators. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176379"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1021\/bi060490t","article-title":"CFTR Expression in Human Neutrophils and the Phagolysosomal Chlorination Defect in Cystic Fibrosis","volume":"45","author":"Painter","year":"2006","journal-title":"Biochemistry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.1073\/pnas.2634339100","article-title":"Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium","volume":"100","author":"Coakley","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1007\/s004240100641","article-title":"CFTR may play a role in regulated secretion by lymphocytes: A new hypothesis for the pathophysiology of cystic fibrosis","volume":"443","author":"Bubien","year":"2001","journal-title":"Pflugers Arch."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Xu, Y., Tertilt, C., Krause, A., Quadri, L.E., Crystal, R.G., and Worgall, S. (2009). Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells. Respir. Res., 10.","DOI":"10.1186\/1465-9921-10-26"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/thoraxjnl-2015-207588","article-title":"Airway surface liquid homeostasis in cystic fibrosis: Pathophysiology and therapeutic targets","volume":"71","author":"Haq","year":"2015","journal-title":"Thorax"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12016-007-8039-9","article-title":"Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling","volume":"34","author":"Nichols","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_18","first-page":"1","article-title":"Airway Epithelium Dysfunction in Cystic Fibrosis and COPD","volume":"2018","author":"Molloy","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zajac, M., Lewenstam, A., Bednarczyk, P., and Dolowy, K. (2020). Measurement of Multi Ion Transport through Human Bronchial Epithelial Cell Line Provides an Insight into the Mechanism of Defective Water Transport in Cystic Fibrosis. Membranes, 10.","DOI":"10.3390\/membranes10030043"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2014.03.006","article-title":"Redox balance in Cystic Fibrosis","volume":"52","author":"Ziady","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rehman, T., Karp, P.H., Tan, P., Goodell, B.J., Pezzulo, A.A., Thurman, A.L., Thornell, I.M., Durfey, S.L., Duffey, M.E., and Stoltz, D.A. (2021). Inflammatory cytokines TNF-\u03b1 and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators. J. Clin. Investig., 131.","DOI":"10.1172\/JCI150398"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2015-0271","article-title":"Neutrophils in cystic fibrosis","volume":"397","author":"Laval","year":"2016","journal-title":"Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcf.2016.05.016","article-title":"Airway inflammation in mild cystic fibrosis","volume":"16","author":"Eckrich","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.4049\/jimmunol.174.3.1638","article-title":"TLR-Induced Inflammation in Cystic Fibrosis and Non-Cystic Fibrosis Airway Epithelial Cells","volume":"174","author":"Greene","year":"2005","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000487057","article-title":"Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine","volume":"10","author":"Hartl","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201104-0617ED","article-title":"IL-17 in Cystic Fibrosis: More Than Just Th17 Cells","volume":"184","author":"Dubin","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Michl, R.K., Hentschel, J., Fischer, C., Beck, J.F., and Mainz, J.G. (2013). Reduced Nasal Nitric Oxide Production in Cystic Fibrosis Patients with Elevated Systemic Inflammation Markers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079141"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1099\/mic.0.000220","article-title":"Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies","volume":"162","author":"Tyrrell","year":"2016","journal-title":"Microbiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jcf.2012.10.010","article-title":"Iron accumulates in the lavage and explanted lungs of cystic fibrosis patients","volume":"12","author":"Ghio","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000446825","article-title":"Cystic Fibrosis Lung Immunity: The Role of the Macrophage","volume":"8","author":"Bruscia","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jaganathan, D., Bruscia, E.M., and Kopp, B.T. (2022). Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147750"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Allard, B., Panariti, A., and Martin, J.G. (2018). Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01777"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 Macrophages and the Th1\/Th2 Paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in cystic fibrosis: An update","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mills, C.D. (2015). Anatomy of a Discovery: M1 and M2 Macrophages. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00212"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/thoraxjnl-2011-200585","article-title":"Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis","volume":"67","author":"Regamey","year":"2011","journal-title":"Thorax"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mai.2001.118516","article-title":"Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis","volume":"108","author":"Hubeau","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1183\/09031936.00178508","article-title":"Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis","volume":"34","author":"Brennan","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1165\/rcmb.2008-0155OC","article-title":"Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis","volume":"41","author":"Meyer","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcf.2017.03.011","article-title":"CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis","volume":"16","author":"Tarique","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1093\/nar\/19.19.5417","article-title":"Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin","volume":"19","author":"Yoshimura","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/JLB.4RU0620-245R","article-title":"Macrophage dysfunction in cystic fibrosis: Nature or nurture?","volume":"109","author":"Turton","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.2008-0170OC","article-title":"Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator\u2212\/\u2212 mice","volume":"40","author":"Bruscia","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.0412188","article-title":"Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection","volume":"92","author":"Bonfield","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ferrari, E., Monzani, R., Villella, V.R., Esposito, S., Saluzzo, F., Rossin, F., D\u2019Eletto, M., Tosco, A., De Gregorio, F., and Izzo, V. (2017). Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation. Cell Death Dis., 8.","DOI":"10.1038\/cddis.2016.476"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gschwandtner, M., Derler, R., and Midwood, K.S. (2019). More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02759"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Uribe-Querol, E., and Rosales, C. (2020). Phagocytosis: Our Current Understanding of a Universal Biological Process. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01066"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ncb1456","article-title":"CFTR regulates phagosome acidification in macrophages and alters bactericidal activity","volume":"8","author":"Di","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"35926","DOI":"10.1074\/jbc.M109.057372","article-title":"Disease-causing Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator Determine the Functional Responses of Alveolar Macrophages","volume":"284","author":"Deriy","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"31422","DOI":"10.1074\/jbc.M705296200","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator-independent Phagosomal Acidification in Macrophages","volume":"282","author":"Haggie","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1091\/mbc.e09-01-0061","article-title":"Revisiting the Role of Cystic Fibrosis Transmembrane Conductance Regulator and Counterion Permeability in the pH Regulation of Endocytic Organelles","volume":"20","author":"Barriere","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2019.09.003","article-title":"Human cystic fibrosis monocyte derived macrophages display no defect in acidification of phagolysosomes when measured by optical nanosensors","volume":"19","author":"Law","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"E6486","DOI":"10.1073\/pnas.1518966112","article-title":"TRPC6 channel translocation into phagosomal membrane augments phagosomal function","volume":"112","author":"Riazanski","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-0993-2","article-title":"Is cellular senescence involved in cystic fibrosis?","volume":"20","author":"Bezzerri","year":"2019","journal-title":"Respir. Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Badr, A., Eltobgy, M., Krause, K., Hamilton, K., Estfanous, S., Daily, K.P., Abu Khweek, A., Hegazi, A., Anne, M.N.K., and Carafice, C. (2022). CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.819554"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.4049\/jimmunol.1201607","article-title":"Reduced Caveolin-1 Promotes Hyperinflammation due to Abnormal Heme Oxygenase-1 Localization in Lipopolysaccharide-Challenged Macrophages with Dysfunctional Cystic Fibrosis Transmembrane Conductance Regulator","volume":"190","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"C263","DOI":"10.1152\/ajpcell.00527.2008","article-title":"Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa","volume":"297","author":"Bajmoczi","year":"2009","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.4049\/jimmunol.1502609","article-title":"Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia","volume":"198","author":"Assani","year":"2017","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.4049\/jimmunol.181.6.4247","article-title":"Acid Sphingomyelinase Amplifies Redox Signaling in Pseudomonas aeruginosa-Induced Macrophage Apoptosis","volume":"181","author":"Zhang","year":"2008","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.celrep.2019.01.071","article-title":"CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses","volume":"26","author":"Bernut","year":"2019","journal-title":"Cell Rep."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Averna, M., Melotti, P., and Sorio, C. (2021). Revisiting the Role of Leukocytes in Cystic Fibrosis. Cells, 10.","DOI":"10.3390\/cells10123380"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1189\/jlb.1108699","article-title":"Pivotal Advance: Expansion of small sputum macrophages in CF: Failure to express MARCO and mannose receptors","volume":"86","author":"Wright","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hazlett, H.F., Hampton, T.H., Aridgides, D.S., Armstrong, D.A., Dessaint, J.A., Mellinger, D.L., Nymon, A.B., and Ashare, A. (2020). Altered iron metabolism in cystic fibrosis macrophages: The impact of CFTR modulators and implications for Pseudomonas aeruginosa survival. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-67729-5"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood.2021014699","article-title":"Neutrophil dysfunction in the pathogenesis of cystic fibrosis","volume":"139","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.201203170","article-title":"Neutrophil extracellular traps: Is immunity the second function of chromatin?","volume":"198","author":"Brinkmann","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Etecchio, C., Micheletti, A., and Cassatella, M.A. (2014). Neutrophil-Derived Cytokines: Facts Beyond Expression. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00508"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.it.2007.06.002","article-title":"Neutrophil granules: A library of innate immunity proteins","volume":"28","author":"Borregaard","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.coi.2019.05.006","article-title":"The phagocyte NOX2 NADPH oxidase in microbial killing and cell signaling","volume":"60","author":"Nauseef","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1710-1492-2-3-98","article-title":"Mechanisms of Degranulation in Neutrophils","volume":"2","author":"Lacy","year":"2006","journal-title":"Allergy. Asthma Clin. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40348-016-0066-2","article-title":"Neutrophil plasticity enables the development of pathological microenvironments: Implications for cystic fibrosis airway disease","volume":"3","author":"Margaroli","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17476348.2016.1204915","article-title":"Diagnosis and Early Life Risk Factors for Bronchiectasis in Cystic Fibrosis: A Review","volume":"10","author":"Sly","year":"2016","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Hayes, E., Murphy, M.P., Pohl, K., Browne, N., McQuillan, K., Saw, L.E., Foley, C., Gargoum, F., McElvaney, O.J., and Hawkins, P. (2020). Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.600033"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Harwood, K., McQuade, R., Jarnicki, A., and Schneider-Futschik, E. (2021). Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147606"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clim.2016.03.016","article-title":"Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23\u2014Dependent IL-17RC","volume":"170","author":"Taylor","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2174\/1389450117666151209120516","article-title":"Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target","volume":"17","author":"Guan","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1523-1755.1998.00741.x","article-title":"Interleukin-8 delays spontaneous and tumor necrosis factor-\u03b1-mediated apoptosis of human neutrophils","volume":"53","author":"Kettritz","year":"1998","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcf.2010.11.005","article-title":"aeruginosa drives CXCL8 synthesis via redundant toll-like receptors and NADPH oxidase in CFTR\u2206F508 airway epithelial cells","volume":"10","author":"Roussel","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1073\/pnas.0813410106","article-title":"Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs","volume":"106","author":"Makam","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood-2010-12-324186","article-title":"Activation of hypoxia-inducible factor-1\u03b1 (Hif-1\u03b1) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model","volume":"118","author":"Elks","year":"2011","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000295791","article-title":"In Cystic Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed and Modulated by Diamide or Roscovitine: Evidence for an Innate Neutrophil Disturbance","volume":"2","author":"Moriceau","year":"2010","journal-title":"J. Innate Immun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/imr.12438","article-title":"Chloride flux in phagocytes","volume":"273","author":"Wang","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.freeradbiomed.2012.10.542","article-title":"Chloride transport in functionally active phagosomes isolated from Human neutrophils","volume":"53","author":"Aiken","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ng, H.P., Zhou, Y., Song, K., Hodges, C.A., Drumm, M.L., and Wang, G. (2014). Neutrophil-Mediated Phagocytic Host Defense Defect in Myeloid Cftr-Inactivated Mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106813"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1189\/jlb.0907658","article-title":"The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils","volume":"83","author":"Painter","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.1800076","article-title":"Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses","volume":"201","author":"Brockman","year":"2018","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Dittrich, A.S., K\u00fchbandner, I., Gehrig, S., Rickert-Zacharias, V., Twigg, M., Wege, S., Taggart, C., Herth, F., Schultz, C., and Mall, M.A. (2018). Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis. Eur. Respir. J., 51.","DOI":"10.1183\/13993003.01910-2017"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm0598-615","article-title":"Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis","volume":"4","author":"Belaaouaj","year":"1998","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk Factors for Bronchiectasis in Children with Cystic Fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1067\/mpd.2002.129847","article-title":"Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis","volume":"141","author":"Sagel","year":"2002","journal-title":"J. Pediatr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1164\/rccm.201205-0875OC","article-title":"Neutrophil Elastase Degrades Cystic Fibrosis Transmembrane Conductance Regulator via Calpains and Disables Channel Function In Vitro and In Vivo","volume":"187","author":"Descamps","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Pruli\u00e8re-Escabasse, V., Clerici, C., Vuagniaux, G., Coste, A., Escudier, E., and Plan\u00e8s, C. (2010). Effect of neutrophil elastase and its inhibitor EPI-hNE4 on transepithelial sodium transport across normal and cystic fibrosis human nasal epithelial cells. Respir. Res., 11.","DOI":"10.1186\/1465-9921-11-141"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Pedrazzi, M., Vercellone, S., Barberis, E., Capraro, M., De Tullio, R., Cresta, F., Casciaro, R., Castellani, C., Patrone, M., and Marengo, E. (2021). Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083928"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ppul.20165","article-title":"Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis","volume":"39","author":"Sagel","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.abb.2016.06.015","article-title":"Abnormal activation of calpain and protein kinase C\u03b1 promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients","volume":"604","author":"Averna","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1183\/09031936.00212114","article-title":"Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis","volume":"46","author":"Garratt","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000444125","article-title":"CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense","volume":"8","author":"Carevic","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1128\/IAI.00922-06","article-title":"Neutrophil Elastase, an Innate Immunity Effector Molecule, Represses Flagellin Transcription in Pseudomonas aeruginosa","volume":"74","author":"Sonawane","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(03)00482-4","article-title":"Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4","volume":"544","author":"Devaney","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Mor\u00e1n, G., Uberti, B., and Quiroga, J. (2022). Role of Cellular Metabolism in the Formation of Neutrophil Extracellular Traps in Airway Diseases. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.850416"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcf.2018.05.018","article-title":"Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function","volume":"18","author":"Forrest","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Miller, L., Singbartl, K., Chroneos, Z.C., Ruiz-Velasco, V., Lang, C.H., and Bonavia, A. (2019). Resistin directly inhibits bacterial killing in neutrophils. Intensive Care Med. Exp., 7.","DOI":"10.1186\/s40635-019-0257-y"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Hagner, M., Albrecht, M., Guerra, M., Braubach, P., Halle, O., Zhou-Suckow, Z., Butz, S., Jonigk, D., Hansen, G., and Schultz, C. (2020). IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease. Eur. Respir. J., 57.","DOI":"10.1183\/13993003.00716-2019"},{"key":"ref_104","first-page":"1178","article-title":"NETosis: Molecular Mechanisms, Role in Physiology and Pathology","volume":"85","author":"Vorobjeva","year":"2020","journal-title":"Biochemistry"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/thoraxjnl-2017-210134","article-title":"Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis","volume":"73","author":"Gray","year":"2017","journal-title":"Thorax"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1165\/rcmb.2016-0193PS","article-title":"Evasion of Neutrophil Extracellular Traps by Respiratory Pathogens","volume":"56","author":"Storisteanu","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Nadesalingam, A., Chen, J.H.K., Farahvash, A., and Khan, M.A. (2018). Hypertonic Saline Suppresses NADPH Oxidase-Dependent Neutrophil Extracellular Trap Formation and Promotes Apoptosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00359"},{"key":"ref_108","unstructured":"European Medicines Agency (2022, August 10). Kaftrio. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaftrio."},{"key":"ref_109","unstructured":"Food and Drug Administration (2022, August 10). Trikafta, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212273s004lbl.pdf."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/AnnalsATS.201909-671CME","article-title":"The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis","volume":"17","author":"Sergeev","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_111","unstructured":"Food and Drug Administration (2022, August 10). Kalydeco, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/203188s019lbl.pdf."},{"key":"ref_112","unstructured":"European Medicines Agency (2022, August 10). Kalydeco. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kalydeco."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: A double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"Munck","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(15)00201-5","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: A double-blind, randomised controlled trial","volume":"3","author":"Moss","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2014-02-555268","article-title":"A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy","volume":"124","author":"Pohl","year":"2014","journal-title":"Blood"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.181.6.3793","article-title":"Rab27a Regulates Exocytosis of Tertiary and Specific Granules in Human Neutrophils","volume":"181","author":"Calafat","year":"2008","journal-title":"J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ppul.23712","article-title":"CFTR-dependent chloride efflux in cystic fibrosis mononuclear cells is increased by ivacaftor therapy","volume":"52","author":"Guerra","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcb.2010.09.006","article-title":"pH regulation and beyond: Unanticipated functions for the voltage-gated proton channel, HVCN1","volume":"21","author":"Capasso","year":"2011","journal-title":"Trends Cell Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.08.013","article-title":"Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease","volume":"23","author":"White","year":"2017","journal-title":"eBioMedicine"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2015.02.010","article-title":"Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor","volume":"15","author":"Bratcher","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Wang, Q., Jia, S., Zheng, J., Xiang, R., Cui, Y., Zhang, J., Xu, Y., and Zhao, M. (2022). Analysis of CFTR gene expression as an immunological and prognostic biomarker in pan-cancers. Comput. Biol. Med., 146.","DOI":"10.1016\/j.compbiomed.2022.105614"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1165\/rcmb.2015-0322LE","article-title":"Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis","volume":"54","author":"Hisert","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Puccetti, M., Pariano, M., Renga, G., Santarelli, I., D\u2019Onofrio, F., Bellet, M.M., Stincardini, C., Bartoli, A., Costantini, C., and Romani, L. (2021). Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting. Cells, 10.","DOI":"10.3390\/cells10071601"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Hoppe, J.E., Wagner, B.D., Harris, J.K., Rowe, S.M., Heltshe, S.L., DeBoer, E.M., and Sagel, S.D. (2022). Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D. J. Cyst. Fibros.","DOI":"10.1016\/j.jcf.2022.03.012"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Hisert, K.B., Birkland, T.P., Schoenfelt, K.Q., Long, M.E., Grogan, B., Carter, S., Liles, W.C., McKone, E.F., Becker, L., and Manicone, A.M. (2020). CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01219"},{"key":"ref_129","first-page":"132","article-title":"The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study","volume":"16","author":"Seegmiller","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Simon, M.A., and Csan\u00e1dy, L. (2021). Molecular pathology of the R117H cystic fibrosis mutation is explained by loss of a hydrogen bond. eLife, 10.","DOI":"10.7554\/eLife.74693"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1165\/rcmb.2019-0107ED","article-title":"Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?","volume":"61","author":"Murphy","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35151-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/17460441.2020.1750592","article-title":"The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis","volume":"15","author":"Guerra","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_134","unstructured":"European Medicines Agency (2022, August 11). Orkambi. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/orkambi."},{"key":"ref_135","unstructured":"Food and Drug Administration (2022, August 11). Orkambi, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/211358s000lbl.pdf."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"L432","DOI":"10.1152\/ajplung.00461.2017","article-title":"Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa","volume":"314","author":"Barnaby","year":"2018","journal-title":"Am. J. Physiol. Cell Mol. Physiol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Jarosz-Griffiths, H.H., Scambler, T., Wong, C.H., Lara-Reyna, S., Holbrook, J., Martinon, F., Savic, S., Whitaker, P., Etherington, C., and Spoletini, G. (2020). Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. eLife, 9.","DOI":"10.7554\/eLife.54556"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcf.2019.08.021","article-title":"Whole-blood transcriptomic responses to lumacaftor\/ivacaftor therapy in cystic fibrosis","volume":"19","author":"Kopp","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Currie, A.J., Main, E.T., Wilson, H.M., Armstrong-James, D., and Warris, A. (2020). CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00372"},{"key":"ref_140","unstructured":"European Medicines Agency (2022, August 11). Symkevi. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/symkevi."},{"key":"ref_141","unstructured":"Food and Drug Administration (2022, August 11). Symdeko, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210491lbl.pdf."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78817-x","article-title":"(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages","volume":"10","author":"Shrestha","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Gillan, J.L., Davidson, D.J., and Gray, R.D. (2020). Targeting Cystic Fibrosis Inflammation in the Age of CFTR Modulators: Focus on Macrophages. Eur. Respir. J., 57.","DOI":"10.1183\/13993003.03502-2020"},{"key":"ref_144","first-page":"1","article-title":"Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment","volume":"11","author":"Shaughnessy","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.202106-1426OC","article-title":"Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis","volume":"205","author":"Casey","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1164\/rccm.202201-0008ED","article-title":"The P2X7 Receptor in Cystic Fibrosis Monocytes: Linking CFTR Deficiency to Inflammation","volume":"205","author":"Cantin","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:50Z","timestamp":1760144150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":146,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms232012421"],"URL":"https:\/\/doi.org\/10.3390\/ijms232012421","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}